ÂÜÀòÂÒÂ×

Dr. Green is currently Managing Director at CT Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for innovative, growing companies in CT. Previously, Cyndi led Search and Evaluation in Worldwide Business Development at Pfizer with responsibility for anti-infectives and vaccines, prior to that she was a lead scientist, then business and investor relations/marketing manager at CuraGen. Her technical leadership at Pfizer led to the formation of Pfizer/GSK spin-out, ViiV Healthcare, as well as the acquisitions of an anti-infective franchise from AZ and vaccine portfolios from Baxter and GSK. Cyndi’s expertise spans the spectrum of drug development in preclinical to marketed assets, technologies, diagnostics and research platforms. In addition to support of CI, she also currently mentors and provides consultant expertise for a variety of organizations, including ABCT, eLabNYC, Springboard Enterprises, and Endless Frontier Labs. Cyndi is currently a board member at CaroGen Corporation and a board observer for a variety of CI portfolio companies.

Prior to relocating back to CT, she was on the board of NewYorkBIO for over a decade and was instrumental in helping foster the growth of biotech in the area. Cyndi received a Doctorate in Molecular Biology at SUNY Buffalo, completed postdoctoral work at Yale University and received an MBA from Rensselaer Polytechnic Institute.